Search | Clinical Trials Finder

ClinicalTrials.gov public records Last synced Sep 22, 2026, 11:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–40 of 16 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Intervention: Low caffeine Clear all

Conditions: Healthy
Interventions: ENGN Shred, Nutricost caffeine powder, Crystal Light; Dietary Supplement
Lead sponsor: Northern Illinois University; Other
Eligibility: 19 Years to 29 Years · Male only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: DeKalb, Illinois

Conditions: Venous Thromboembolic Disease, Pulmonary Embolism and Thrombosis, Deep Vein Thrombosis, Hospitalism
Interventions: EHR (electronic health record) alert, No EHR (electronic health record) alert; Other
Lead sponsor: Scott C. Woller, MD; Other
Eligibility: 18 Years to 110 Years
Enrollment: 152,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Murray, Utah

Conditions: Down Syndrome, Autonomic Dysfunction
Interventions: Fear Response, Cold Stress, Pain Response, Caffeine, 12-Hour Fast, Maximal Dynamic Exercise; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 50 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Depression, Major Depressive Disorder
Interventions: MoodTriggers Application; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Hanover, New Hampshire • Lebanon, New Hampshire

Conditions: Caffeine
Interventions: no caffeine, high caffeine, no theobromine, low theobromine, high theobromine; Dietary Supplement
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 55 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Migraine Disorders
Interventions: caffeine/propranolol combination tablet, placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Stanford, California

Conditions: Retinopathy of Prematurity
Interventions: Caffeine citrate, Ibuprofen, Ketorolac; Drug
Lead sponsor: State University of New York - Downstate Medical Center; Other
Eligibility: Up to 28 Weeks
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Leiomyoma, Uterine
Interventions: Green Tea Extract, Placebo; Drug · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 4
States / cities: New Haven, Connecticut • Chicago, Illinois • Baltimore, Maryland

Conditions: Maternal Care Patterns
Interventions: Mom-Net, Coach-facilitated Treatment as Usual; Behavioral
Lead sponsor: Oregon Research Institute; Other
Eligibility: Female only
Enrollment: 266 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 2
States / cities: Eugene, Oregon

Conditions: Hyperlipemia, Mixed, ASCVD
Interventions: Alert; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sleep Quality
Interventions: Risk Stratification, Usual Care; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Postoperative Delirium, Postoperative Cognitive Dysfunction, Mild Cognitive Impairment
Interventions: Dextrose Water, Caffeine citrate; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 70 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Diarrhea, HIV Infections
Interventions: Dietary intervention, HIV Self-Care; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2003
U.S. locations: 1
States / cities: New York, New York

Conditions: Acute Kidney Injury
Interventions: Level A, Level B, Passive Alert; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 698 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 8
States / cities: Altoona, Pennsylvania • Farrell, Pennsylvania • McKeesport, Pennsylvania + 3 more

Conditions: Hypoxic-Ischemic Encephalopathy
Interventions: Caffeine Citrate 5 mg/kg, Caffeine Citrate 10 mg/kg; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: Up to 24 Hours
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions: Interventional Diet; Other
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Loma Linda, California

Search by objective public record fields.

Pre-workout Supplement Versus Caffeine on Energy Expenditure.

Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome

Remote Evaluation and Alerting for Collaborative Health (REACH) in Depression

Effects of a Cocoa Shot on the Human Brain 2

Caffeine/Propranolol Intervention for Acute Migraine

Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)

FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea

Depressed Mothers in Rural Areas: Web-Facilitated Cognitive Behavioral Treatment

Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein Management

Identifying At-Risk Patients and Predicting Deterioration of In-Patients Using Continuous Heart Rate, Respiratory Rate, and Movement Monitoring

The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study

The Healthy Life Choices Project in HIV-Positive Patients

Multi-hospital Electronic Decision Support for Drug-associated Acute Kidney Injury

Caffeine for Hypoxic-Ischemic Encephalopathy

Di-PKD: A Pilot Trial of Dietary Intervention in Patients With Autosomal Dominant Polycystic Kidney Disease